European Regulatory Round Up: While EMA Opens Up, European Pharma Battens Down For Tough Year
Executive Summary
The European Medicines Agency is focusing on transparency and pharmacovigilance over the next year, while the pharmaceutical industry is gearing up for a fight against austerity measures.
You may also be interested in...
EMA Revamp Could Be Hampered By Tight Budget And Staffing
The European Medicines Agency plans a major restructuring plan to better aid its stakeholders, including firms considering OTC switch proposals or introducing other new OTCs, but tight staffing levels and budget stagnation could hamper the effort.
EMA Revamp Could Be Hampered By Tight Budget And Staffing
The European Medicines Agency plans a major restructuring plan to better aid its stakeholders, including firms considering OTC switch proposals or introducing other new OTCs, but tight staffing levels and budget stagnation could hamper the effort.
EMA’s Heralded Revamp May Be Hampered By Tight Budget And Staffing
The EMA has announced a major restructuring plan to better aid its stakeholders, but tight staffing levels and budget stagnation could hamper the effort.